YoungA.W., SweeneyE.W., DavidD.S., CheighJ., HochgelerentE.L., SakaiS.Dermatologic evaluation of pruritus in patients on hemodialysis.N Y State J Med1973; 73: 2670–4.
2.
GilchrestB.A., RoweJ.W., BrownR.S., SteinmanT.I., ArndtK.A.Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanisms of action.Ann Intern Med1979; 91: 17–21.
3.
GarssenJ., VandebrielR.J., DeGruijlF.R., WolversD.A., Van DijkM., FluitmanA.UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses.Immunology1999; 97: 506–14.
4.
McHughS.M., RifkinI.R., DeightonJ., WilsonA.B., LachmannP.J., LockwoodC.M.The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.Clin Exp Immunol1995; 99: 160–7.
5.
SilvaS.R.B., VianaP.C.F., LugonN.V., HoetteM., RuzanyF., LugonJ.R.Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial.Nephron1994; 67: 270–3.
